Home
Print E-mail
a_slide
aa_slide
aaa_slide
aaaa_slide
aab
bb
DSC_8493
DSC_8509
e
IMG_4850
IMG_4978
IMG_5094
IMG_5128
IMG_5141
IMG_5147
IMG_5202
IMG_5385
IMG_5627
IMG_5790
IMG_5800
IMG_6394
IMG_6395
IMG_6550
IMG_6709
IMG_6775
IMG_6791
IMG_7239
01/27 
start stop bwd fwd


Split, June 28th 2013. – Central European scientific event in 2013, “The 8th ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine”, was successfully completed. More than 550 participants and 70 lecturers from 45 countries attended the congress, and lectures were, amongst others, held by Nobel Prize laureates Ada Yonath (Weizmann Institute of Science), Aaron Ciechanover (Technion), Robert Huber (Max Planck Institute of Biochemistry).This biannual congress was founded by prof.dr. Dragan Primorac, prof.dr. Moses Schanfield and prof.dr. Stanimir Vuk-Pavlović.

Congress was officially opened by the chief of the EU delegation in Croatia Paul Vandoren who stated: „ Croatia worked hard over the last 10 years in order to prepare for the entry into the European family“. Vandoren received a standing ovation when he finished his address by saying: „ Congratulations Croatia, welcome Croatia, good luck Croatia! “

Scientific committee of the International Society of Applied Biological Sciences (ISABS) brought forth many conclusions in terms of development of clinical and forensic molecular genetics in the period ahead, including the following:

  • ISABS will work on strengthening the concept of personalized medicine where treatments will be adjusted to each individual in accordance with the build and structure of his/her genome
  • All countries that have failed to do so should urgently synchronized their legislations in order to ensure legal framework for the exchange of DNA data when searching for felons.
  • ISABS has accepted the development concept of the new technology which is to be used by the police. The so called „rapid DNA technology“ will enable us to get the profile of a perpetrator of a crime in approximately 60 minutes,
  • ISABS will pay special attention to the education of students throughout the world as well as reward the very best among them
  • The next, 9th ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine, will be held in Croatia 2015,
  • Instead one issue that was published every other year, the ISABS will be publishing one thematic issue of the Croatian Medical Journal every year.

During the congress, subjects such as „Cyber crime“, DNA analysis in judiciary-medical practice, analysis of plant and animal DNA for the purpose of forensic testing, importance of DNA data bases in the discovery of criminal offenders, molecular anthropology and the research of the origin of nations, DNA identification of mass disaster victims and many others were covered. 

In the clinical part of the congress topics covered the latest achievements in regenerative medicine, gene and cell therapy, individualized medicine, new molecular procedures and methodology for early detection of cancer, clinical importance of circulating tumor cells and immune therapy in cancer treatments.

Invited speakers of 8th ISABS Conference:

Inaugural Plenary Session: Science and Public Security

Zvia Agur (Institute for Medical BioMathematics, Tel Aviv, Israel): Can one theory guide both personalized medicine and national security policies?
Christopher Asplen (Global Alliance for Rapid DNA Testing, Chalfont, Pennsylvania, USA): Future impact of rapid DNA technology on law enforcement
Isaac Ben-Israel (Tel Aviv University, Tel Aviv, Israel): Forensics of cyber crime: The problem of attribution
Henry Lee (University of New Haven, West Haven, Connecticut, USA): Application of DNA evidence in public safety
Andre Terzic (Mayo Clinic, Rochester, Minnesota, USA): Regenerative medicine: a new paradigm

Nobel Lectures
Aaron Ciechanover (Nobel Prize in Chemistry 2004; Technion, Haifa, Israel): Revolution of personalized medicine: Will we cure all diseases and at what cost?
Robert Huber (Nobel Prize in Chemistry 1988; Max-Planck-Institute, Martinsried, Germany): Protein structures at the interface of physics, chemistry and biology
Ada Yonath (Nobel Prize in Chemistry 2009; Weizmann Institute of Science, Rehovot, Israel): From basic science to better antibiotics

Forensic Program
Šimun Anđelinović (University of Split, Split, Croatia): Virtual authopsy and forensic anthropology of mummified saint bodies
Kenneth Aschheim (New York University, New York, New York, USA): Forensic odontology in disaster victim identification: new technologies
Kaye Ballantyne (Victoria Police Forensic Services Department, Macleod, Victoria, Australia): Improved forensic Y-chromosome analysis
Corina Benschop (Netherlands Forensic Institute,Hague, The Netherlands): Low template DNA analysis and interpretation
Frederick Bieber (Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA): Role of statistical genetics in mass disaster management
Veronique Bourdon (Azur Genetique, Nice, France): Optimization of human mtDNA control region sequencing for forensic applications.
Zoran Budimlija (Office of Chief Medical Examiner, New York City, New York, USA): Twelve years of World Trade Center Human Identification Project
Barbara Butcher (Office of Chief Medical Examiner, New York City, New York, USA): Science of mass fatality management
Cassandra Calloway (Children's Hospital & Research Center Oakland, Oakland, California, USA): Analysis of DNA mixtures and degraded DNA by clonal sequencing
Theresa Caragine (Office of Chief Medical Examiner, New York City, New York, USA): Forensic casework after 9/11: Implementing new technologies
Angel Carracedo (University of Santiago de Compostela, Santiago de Compostela, Spain): New genomic technologies in forensic science
Katja Drobnič (National Forensic Laboratory, Ljubljana, Slovenia): Advanced methods in forensic practice
Santo Davide Ferrara (University of Padua, Padua, Italy): Perspectives of biomedicolegal sciences
Benjamin Figura (Office of Chief Medical Examiner, New York, New York, USA): Anthropology and fingerprinting: New techniques for identification
Dan Frumkin (Nucleix, Tel Aviv, Israel): Forensic epigenetics
Cordula Haas (Institute of Legal Medicine, University of Zürich, Zürich, Switzerland): Gene expression in forensic sciences
Mitchell Holland (Penn State University, University, Pennsylvania, USA): Forensic applications of NextGen Sequencing on 454 LifeSciences GS Junior and Illumina MiSeq instruments
Ed Huffine (Bode Technology, Lorton, Virginia, USA): From Forensic Investigations to Medical Applications, the Increasing Impact of DNA Testing
Manfred Kayser (University of Rotterdam, Rotterdam, The Netherlands): Forensic DNA phenotyping
Peter de Knijff (University of Leiden, Leiden, The Netherlands): Deep sequencing of 750 complete Dutch mtDNA genomes using NextGen Sequencing
Timothy Palmbach (University of New Haven, Connecticut, USA): Leveraging the power of DNA analysis in the war on human trafficking
Walther Parson (Institute of Legal Medicine, Innsbruck Medical University, Insbruck, Austria): Forensic applications of NextGen Sequencing on LifeTechnologies Ion PGM instrument
Dragan Primorac (University of Split and University of Osijek, Croatia; Penn State University and University of New Haven, USA): Epigenetic predictors of age
Antti Sajantila (University of Helsinki, Helsinki, Finland): Progress in forensic pharmacogenomics
Moses Schanfield (George Washington University, Washington, District of Columbia, USA): Population variation in X chromosome STR markers: Forensic and anthropologic considerations
Peter Vallone (National Institute of Standards and Technology, Gaithersburg, Maryland, USA): Characterization of reference standards with NextGen Sequencing platforms
Elisa Wurmbach (Office of Chief Medical Examiner, New York City, New York, USA): Improved eye and skin color prediction based on 8 SNPs

Translational Medicine Program
Chiara Bonini (San Raffaele Scientific Institute, Milan, Italy): TCR gene editing for treatment of hematological malignancies
Malcolm Brenner (Baylor College of Medicine, Houston, Texas, USA): How to make T cells a standard of care for cancer?
Renier Brentjens (Memorial Sloan-Kettering Cancer Center, New York, New York, USA): Moving CAR modified T cell therapy of cancer forward in the clinic
Robert Deans (Athersys Inc, Cleveland, Ohio, USA): Adherent stem cells for CNS injury
Henry Erlich (Roche Molecular Systems, Pleasanton, California, USA): Next Generation Sequencing in analysis of HLA polymorphism: clinical and research applications
Arezou Ghazani (Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts, USA): Advances in nanotechnology and diagnostics
David Goldstein (Duke University, Durham, North Carolina, USA): Exome sequencing of rare monogenic diseases
Michael Jensen (Seattle Children's Hospital, Seattle, Washington, USA): Enhancing IQ of chimeric antigen receptor-redirected T cells
Doron Lancet (Weizmann Institute of Science, Rehovot, Israel): Biological tales of human disease mutations
Steven Moran (Mayo Clinic, Rochester, Minnesota, USA): Hand and face transplantation at Mayo Clinic
Moien Kanaan (Bethlehem University, Bethlehem, Palestine): Towards the application of exome sequencing in the clinic
Franklyn Prendergast (Mayo Clinic, Rochester, Minnesota, USA): Heterogeneity and accuracy of diagnostics for personalized medicine
Yoel Rak (Tel-Aviv University, Tel Aviv, Israel): Neanderthal man's place in nature
Dražen Raucher (University of Mississippi, Jackson, Mississippi, USA): Thermoresponsive biopolymers for tumor-specific drug delivery
Isobel Scarisbrick (Mayo Clinic, Rochester, Minnesota, USA): Pharmacological approach to spine cord injury regeneration
John Sinden (ReNeuron, Guildford, Surrey, United Kingdom): Neuronal cell therapy for stroke
Rafael Sierra (Mayo Clinic, Rochester, Minnesota, USA): Hip decompression by bone marrow concentrate in early osteonecrosis of femoral head
David I. Smith (Mayo Clinic, Rochester, Minnesota, USA): Next generation transcriptome analysis of human cancer
Carmen Terzic (Mayo Clinic, Rochester, Minnesota, USA): Cardiac circulating progenitor cells and cardiac regeneration
Peter Underhill (Stanford University, Stanford, California, USA): Patterns of Y-chromosome diversification
Richard Villems (University of Tartu and Estonian Biocentre, Tartu, Estonia): Genetics of Slavic-speaking peoples: Patrilineal, matrilineal and autosomal portraits
Stanimir Vuk-Pavlović (Mayo Clinic, Rochester, Minnesota, USA): Stemness arisen
Peter de Waele (Cardio3 Biosciences, Mont-Saint-Guibert, Belgium): Treating congestive heart failure by autologous adherent progenitors
Scott Waldman (Thomas Jefferson University, Philadelphia, Pennsylvania, USA): A common molecular mechanism at the intersection of obesity and colorectal cancer
Raphael Zidovetzki (University of California Riverside, Riverside, California, USA): Genetic scrutiny of systemic lupus erythematosus, a prototypic autoimmune disease

Workshop "Adapting Clinical Trials to Modern Cancer Therapy"
Zwi Berneman (University of Antwerp, Antwerp, Belgium): Clinical perspectives of immunotherapy of hematopoietic malignancies
Moran Elishmereni (Institute for Medical BioMathematics, Tel Aviv, Israel): Dynamic personalization of clinical trials 1
Mauro Gasparini (Politecnico di Torino, Torino, Italy): New statistical tools fornovel approaches to clinical trials in personalized medicine
Yuri Kogan (Institute for Medical BioMathematics, Tel Aviv, Israel): Dynamic personalization of clinical trials 2
Manish Kohli (Mayo Clinic, Rochester, Minnesota, USA): Use of biomarkers in personalized therapy of prostate cancer

Workshop "Glycoscience in Personalized Medicine"
Harry Campbell (University of Edinburgh, Edinburgh, Scotland, United Kingdom): IgG and plasma glycome in colorectal cancer
John Hannover (National Institutes of Health, Behesda, Maryland, USA): Hexosamine signalling pathway
Gordan Lauc (University of Zagreb, Zagreb, Croatia): Common polymorphisms in glycosylation and human diseases
Dirk Lefeber (Radboud University, Nijmegen, The Netherlands): Congential disorders of glycosylation
Falk Nimmerjahn (Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany):Role of Fc glycosylation in IgG function
Igor Rudan (University of Edinburgh, Edinburgh, Scotland, United Kingdom): GWAS analysis of the human plasma glycome
Tim Spector (Kings College London, London, England, United Kingdom): Genetics and epigenetics of IgG glycosylation in twins
Vlatka Zoldoš (University of Zagreb, Zagreb, Croatia): Epigenetic regulation of protein glycosylation

8th ISABS Conference Last Brochure

8th ISABS Conference Brochure


 
Hosting: Ilimitada Hosting Chile VPS